KleberFertrinMDPhD
Hematology • Seattle, WABlood Banking & Transfusion Medicine, Sickle Cell & Other Anemias
Assistant Professor
Dr. Fertrin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Avenue East
MS LG-700
Seattle, WA 98109Phone+1 206-606-2045Fax+1 206-606-1130
Summary
- Dr. Kleber Fertrin is a hematologist specialized in Classical Hematology in Seattle, WA with an extensive background in Molecular Biology, Transfusion and Laboratory Medicine. His main clinical and research interests are hemolytic anemias, particularly sickle cell disease, thalassemias, iron overload, hemochromatosis, and rare diseases, such as pyruvate kinase deficiency, and variant hemoglobins.
Education & Training
NIH Clinical CenterPost-Doctoral Fellowship, 2013 - 2014
University of Campinas Faculty of MedicineClass of 2003
Certifications & Licensure
WA State Medical License 2018 - 2025
Clinical Trials
- Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major Start of enrollment: 2012 Aug 01
- Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis Start of enrollment: 2016 Nov 01
- A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD) Start of enrollment: 2018 Aug 09
- Join now to see all
Publications & Presentations
PubMed
- Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis.Oyebimpe O Adesina, Isaac C Jenkins, Fábio Galvão, Ana C de Moura, Kleber Y Fertrin
Osteoporosis International. 2025-01-01 - 2 citationsRates of strokes in Californians with sickle cell disease in the post-STOP era.Olubusola Oluwole, Ann M Brunson, Oyebimpe O Adesina, Shaina M Willen, Theresa H M Keegan
Blood. 2024-12-12 - A Winding Road to Health Care Equity in Sickle Cell Disease.Ritika Walia, Kleber Y Fertrin, Daniel E Sabath
Clinics in Laboratory Medicine. 2024-12-01
Abstracts/Posters
- Abnormal Cytokine Production By Mast Cell Cultures from Sickle Cell Anemia Patients in Response to Inflammatory Stimuli and to Co-Culture with EosinophilsKleber Yotsumoto Fertrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Safe Use of Hydroxyurea in Sickle Cell Disease Patients Hospitalized for Painful Vaso-Occlusive Episodes: Results of the Randomized, Open-Label Helps StudyKleber Yotsumoto Fertrin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
Blood Clots and CancerSeptember 20th, 2023- FDA Approves Gene Editing Technology to Treat Sickle Cell Disease: HealthLinkJanuary 7th, 2024
Professional Memberships
- Member
Other Languages
- Portuguese, German
External Links
- SCCA profilehttps://www.seattlecca.org/providers/kleber-fertrin
- UW profilehttps://hematology.uw.edu/faculty/kleber-yotsumoto-fertrin-md-phd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
